0001628280-24-023653.txt : 20240515
0001628280-24-023653.hdr.sgml : 20240515
20240515174923
ACCESSION NUMBER: 0001628280-24-023653
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240513
FILED AS OF DATE: 20240515
DATE AS OF CHANGE: 20240515
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DIAZ PAUL J
CENTRAL INDEX KEY: 0001194247
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26642
FILM NUMBER: 24952903
MAIL ADDRESS:
STREET 1: 680 SOUTH FOURTH STREET
CITY: LOUISVILLE
STATE: KY
ZIP: 40202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MYRIAD GENETICS INC
CENTRAL INDEX KEY: 0000899923
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 870494517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 322 NORTH 2200 WEST
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84116
BUSINESS PHONE: 801-584-3600
MAIL ADDRESS:
STREET 1: 322 NORTH 2200 WEST
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84116
4
1
wk-form4_1715809753.xml
FORM 4
X0508
4
2024-05-13
0
0000899923
MYRIAD GENETICS INC
MYGN
0001194247
DIAZ PAUL J
322 NORTH 2200 WEST
SALT LAKE CITY
UT
84116
1
1
0
0
President and CEO
0
Common Stock
2024-05-13
4
S
0
57844
25.1288
D
1236166
D
Common Stock
2024-05-14
4
S
0
95000
25.2084
D
1141166
D
Common Stock
2024-05-15
4
S
0
75000
25.0722
D
1066166
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.83, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.915 to $25.49, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.64 to $25.60, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
By: Justin Hunter For: Paul J. Diaz
2024-05-15